Breast Cancer
From the Journals
Interplay of TP53, ESR2 may expand treatment options for some TNBCs
Study finds interaction of TP53 mutational status and ESR2 expression influences survival in triple-negative breast cancer and suggests tamoxifen...
News
FDA approves T-DM1 as adjuvant treatment
The antibody-drug conjugate is approved for patients with HER2-positive early breast cancer who have residual invasive disease following...
Conference Coverage
Opioid management program reduced number of narcotics prescribed after breast surgery
Researchers examined 100 consecutive patients after a 3-month implementation period and found a statistically significant reduction in median...
From the Journals
Subcutaneous or IV trastuzumab? Take your pick
Long-term follow-up of women with early, HER2-positive breast cancer showed similar efficacy and safety for subcutaneous or intravenous...
Conference Coverage
Novel CAR T, anti-PD-1 combo shows promise in MPD
ATLANTA – Intrapleurally administered, mesothelin-targeted CAR T-cell therapy combined with PD-1 inhibition showed antitumor activity without...
From the Journals
Immunotherapy overtaking breast cancer treatment landscape
Review authors suggest combination therapy strategies will be the way forward for immunotherapy in breast cancer, with an improved understanding...
From the Journals
ACP: Average-risk women under 50 can postpone mammogram
Reducing breast cancer overdiagnosis and overtreatment was a goal of the ACP guideline’s authors.
News
FDA approves palbociclib for men with HR+/HER2- advanced breast cancer
The FDA advises health care providers to tell male patients with female partners of reproductive potential to use effective contraception during...
News
FDA proposes updates to mammography regulations
Key among the proposed changes is the addition of breast density information to notices for both patients and doctors.
From the Journals
Anastrozole/fulvestrant prolongs OS in metastatic ER+ breast cancer
Women with no prior tamoxifen exposure benefited most from the combination, compared with those receiving anastrozole alone.
From the Journals
Breast cancer survivors offer realistic strategies for easing cost burden
Breast cancer survivors provide recommendations across four significant areas: insurance, supportive services and care, financial assistance, and...